ACS & ASCO are Stronger Together: Cancer.Net content is now available on cancer.org.
Our team of experts brings you cancer-related news, features, and survivor stories.
For the latest news about research we conduct and fund, see ACS Research News.
Published on: June 13, 2024
A recent study shows that giving immunotherapy before surgery for stage III melanoma can help stop the spread of the disease and cut time spent in treatment.
Published on: June 13, 2024
A study shows that a targeted therapy drug stops the spread of lung cancer for 5 years or more. The drug, lorlatinib (Lobrena), also stops new cancer growth in the brain.
Published on: June 13, 2024
A study has shown that giving patients with lung cancer a targeted therapy drug after combined chemotherapy and radiation therapy helps them live longer without the cancer growing or spreading.
Published on: June 13, 2024
A study of almost 3.5 million people confirmed that immunization against the human papillomavirus (HPV) lowers the chances of developing cancers caused by HPV.
Published on: June 13, 2024
For Black women with breast cancer, the chemotherapy drug docetaxel causes less nerve damage than the chemotherapy drug paclitaxel.
Published on: June 1, 2023
Follow research highlighted each day in this ongoing meeting by checking out the ASCO News Highlights for People with Cancer blog.
Published on: October 26, 2022
Women who use chemical hair straighteners and relaxers may have a higher risk of uterine cancer, according to a new study from researchers at the US National Institutes of Health (NIH).
Published on: July 2, 2021
The annual scientific and clinical Journal Impact Factors were released on June 30, and the American Cancer Society’s CA: A Cancer Journal for Clinicians outperformed. The CA impact factor climbed from 292.3 last year to a staggering 508.7 and remains the highest-rated oncology journal in the world.
If this was helpful, donate to help fund patient support services, research, and cancer content updates.